Insider Shareholders with Direct Ownership of Enanta Pharmaceuticals Inc (ENTA)
This section provides a comprehensive overview of the insiders with direct ownership of Enanta Pharmaceuticals Inc (ENTA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ENANTA PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jay R. Luly
President and CEO |
250,108 | 109,779 | 810,609 $8.88 Million | 22 |
Feb 12, 2024
Reduced 0.2%
|
|
Yat Sun Or
Chief Scientific Officer |
98,249 | 30,869 | 373,295 $4.09 Million | 18 |
Feb 12, 2024
Reduced 0.29%
|
|
Paul J Mellett
Chief Fin. & Admin Officer |
89,736 | 36,664 | 95,896 $1.05 Million | 23 |
Feb 12, 2024
Reduced 1.0%
|
|
Nathaniel S. Gardiner
Chief Legal Officer |
81,522 | 15,824 | 75,688 $828,783 | 18 |
Feb 26, 2024
Added 6.41%
|
|
Brendan Luu
Chief Business Officer |
50,337 | 11,254 | 39,083 $427,958 | 11 |
Feb 12, 2024
Reduced 2.43%
|
|
Nathalie Adda
Sr. VP & Chief Medical Officer |
195,954 | 176,606 | 34,982 $383,052 | 24 |
Apr 04, 2022
Reduced 20.48%
|
|
Tara Lynn Kieffer
Chief Product Strategy Officer |
51,233 | 18,892 | 32,341 $354,133 | 12 |
Jun 17, 2024
Reduced 18.35%
|
|
Scott T. Rottinghaus
Chief Medical Officer |
34,951 | 16,167 | 18,784 $205,684 | 11 |
Aug 08, 2024
Reduced 7.24%
|
|
Terry Vance
Director |
5,800 | 15,295 | 5,800 $63,509 | 2 |
Dec 13, 2023
Reduced 72.51%
|
|
Bruce L A Carter
Director |
6,000 | 6,000 | 0 $0 | 2 |
Mar 21, 2022
Reduced 100.0%
|